Literature DB >> 1384227

An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part II: Epitheliosis and ductal carcinoma in situ.

W Böcker1, B Bier, G Freytag, B Brömmelkamp, E D Jarasch, G Edel, B Dockhorn-Dworniczak, K W Schmid.   

Abstract

A detailed immunohistochemical study has been carried out on 63 breast lesions with epitheliosis, ductal carcinoma in situ and clinging carcinoma (lobular cancerization), using antibodies directed against keratins 5/14 and 14, 15, 16, 18, 19, vimentin, smooth muscle actin, collagen IV and laminin. The results have shown that epitheliosis on the one hand and ductal in situ and clinging carcinoma on the other are immunohistochemically different epithelial lesions. Epitheliosis appears to be epithelial hyperplasia with keratin 5/14 and keratin 14, 15, 16, 18, 19-positive cells. Compared to epitheliotic cells tumor cells of clinging carcinoma, lobular cancerization and ductal carcinoma in situ expressed only luminal keratins 14, 15, 16, 18, 19 in 85% of the cases studied; whereas in 15% there was a basal keratin expression. From our results we conclude that the clinging carcinoma (lobular cancerization) represents the initial morphological step in the development of ductal carcinoma in situ and thus may be interpreted as a minimal ductal neoplasia. With the immunohistochemical demonstration of basal and luminal keratins it may be possible in individual cases to differentiate between benign and malignant in situ lesions of the breast.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384227     DOI: 10.1007/bf01660979

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  22 in total

1.  An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part I: Normal breast and benign proliferative lesions.

Authors:  W Böcker; B Bier; G Freytag; B Brömmelkamp; E D Jarasch; G Edel; B Dockhorn-Dworniczak; K W Schmid
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions.

Authors:  S R Wellings; H M Jensen; R G Marcum
Journal:  J Natl Cancer Inst       Date:  1975-08       Impact factor: 13.506

3.  Characterization of breast carcinomas by two monoclonal antibodies distinguishing myoepithelial from luminal epithelial cells.

Authors:  R B Nagle; W Böcker; J R Davis; H W Heid; M Kaufmann; D O Lucas; E D Jarasch
Journal:  J Histochem Cytochem       Date:  1986-07       Impact factor: 2.479

4.  [General explanations on the histomorphology of breast diseases].

Authors:  K Prechtel
Journal:  Fortschr Med       Date:  1974-03-21

5.  [Pathological and anatomical aspects of organ-preserving therapy in the early stages of breast cancer].

Authors:  H E Stegner
Journal:  Osterr Z Onkol       Date:  1975

6.  Epitheliosis of the breast. An immunohistochemical characterization and comparison to malignant intraductal proliferations of the breast.

Authors:  U Raju; J D Crissman; R J Zarbo; C Gottlieb
Journal:  Am J Surg Pathol       Date:  1990-10       Impact factor: 6.394

7.  Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence.

Authors:  M D Lagios; F R Margolin; P R Westdahl; M R Rose
Journal:  Cancer       Date:  1989-02-15       Impact factor: 6.860

8.  Precancerous mastopathie: structural and biological considerations.

Authors:  M M Black; S Kwon
Journal:  Pathol Res Pract       Date:  1980       Impact factor: 3.250

9.  Risk factors for breast cancer in women with proliferative breast disease.

Authors:  W D Dupont; D L Page
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

10.  Antibody markers of basal cells in complex epithelia.

Authors:  P E Purkis; J B Steel; I C Mackenzie; W B Nathrath; I M Leigh; E B Lane
Journal:  J Cell Sci       Date:  1990-09       Impact factor: 5.285

View more
  20 in total

Review 1.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.

Authors:  R K Hansen; M J Bissell
Journal:  Endocr Relat Cancer       Date:  2000-06       Impact factor: 5.678

2.  Progesterone decreases levels of the adhesion protein E-cadherin and promotes invasiveness of steroid receptor positive breast cancers.

Authors:  Anastasia Kariagina; Jianwei Xie; Ingeborg M Langohr; Razvan C Opreanu; Marc D Basson; Sandra Z Haslam
Journal:  Horm Cancer       Date:  2013-08-31       Impact factor: 3.869

3.  [The significance of "normal tissue" in the development of breast cancer: new concepts of early carcinogenesis].

Authors:  H Bürger; C Kersting; D Hungermann; T Decker; W Böcker
Journal:  Pathologe       Date:  2006-09       Impact factor: 1.011

4.  CD44s is useful in the differentiation of benign and malignant papillary lesions of the breast.

Authors:  G M K Tse; P-H Tan; T K F Ma; C B Gilks; C S P Poon; B K B Law
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

Review 5.  Significance of immunohistochemistry in breast cancer.

Authors:  Dana Carmen Zaha
Journal:  World J Clin Oncol       Date:  2014-08-10

6.  [Flat epithelial neoplasia and other columnar cell lesions of the breast].

Authors:  F R Fritzsche; M Dietel; G Kristiansen
Journal:  Pathologe       Date:  2006-09       Impact factor: 1.011

7.  Spectrum of carcinoembryonic antigen immunoreactivity from isolated ductal hyperplasias to atypical hyperplasias associated with infiltrating ductal breast cancer.

Authors:  F C Schmitt; L Andrade
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

8.  [Immunohistochemistry in breast pathology: differential diagnosis of epithelial breast lesions].

Authors:  W Böcker; D Hungermann; S Weigel; J Tio; T Decker
Journal:  Pathologe       Date:  2009-02       Impact factor: 1.011

Review 9.  BRCA1 functions as a breast stem cell regulator.

Authors:  W D Foulkes
Journal:  J Med Genet       Date:  2004-01       Impact factor: 6.318

10.  Oxytocin inhibits proliferation of human breast cancer cell lines.

Authors:  P Cassoni; A Sapino; F Negro; G Bussolati
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.